Robin McAlister

Senior Interstitial Lung Disease Sales Consultant @Boehringer Ingelheim

Greenville, SC, US

Successfully launched and currently promote Ofev, an orphan drug, to Pulmonologists for the treatment of Idiopathic Pulmonary Fibrosis, a rare disease. Promotion also includes Systemic Sclerosis Associated Interstitial Lung Disease as well as any Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype. Leverage a proactive and customer-centric approach based on situational needs and business requirements (i.e. compliance) while customizing sophisticated product presentations based on audience needs.>> Attained 156% territory volume increase during launch period-40% above national average.>> Contributed to team attainment of 450% of goal during Ofev launch>> Quickly built strong relationships in all accounts while launching a novel Orphan Drug therapy in an untapped rare disease market.>> Successfully educated support staff on product information, patient support resources and how to optimally utilize contracted specialty pharmacies encompassing all aspects of drug acquisition.>> Penetrated closed government account through leveraging of rapidly established internal and external networks once joining Boehringer.>> Successfully implemented launch plan that imparted a sense of urgency by strategically teaming with internal resources to provide comprehensive service and support to all accounts.

Texas A&M University

BBA in Management with a Minor in Life Science

University of Dallas

MBA with a Concentration in Marketing (Summa cum Laude)